Sanuwave Health Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
UltraMIST Consumables Revenue Quarterly6.7MTarget: Continued double-digit year-over-year growth to offset capital equipment headwinds
Active UltraMIST Systems in the Field Quarterly1.4KTarget: Expansion of active footprint in hospitals, wound centers, and long-term care facilities
Quarterly Revenue Quarterly9.6MTarget: 8.5 million to 9.5 million for Q2 2026
Watch Items
- CMS Reimbursement Clawbacks and Skin Substitute Pricing ChangesTrigger: Further wound-care clinic closures or reduction in practitioner activityAction: Assess impact on capital equipment demand and adjust sales strategy toward consumables and reseller channels
- Capital Equipment Market Demand for UltraMIST SystemsTrigger: Continued cannibalization of new system sales by used UltraMIST systemsAction: Re-evaluate pricing models, trade-in programs, or shift focus to recurring consumable-based revenue streams
Research as of 20 Jun 2026